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Polymerase chain reaction (PCR) has been recently incorporated as a diagnostic tool for
the diagnosis of tuberculosis. The benefit of rapid results and greater sensitivity com-
pared with traditional microbiological methods makes PCR a suitable technique in
childhood tuberculosis, especially when diagnosis is difficult or when urgent diagnosis
is needed. However, the possibility of false-positive results must be considered, espe-
cially if the clinical and epidemiologic context of the child make the diagnosis of
tuberculosis improbable. The commercial ‘Amplicor PCR test’ lacks good sensitivity
and specificity and it would be necessary to develop other commercial easy-to-use PCR
kits that provides better yield.
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Tuberculosis continues to be a major health pro-
blem in the world. Annually, in developing coun-
tries, there are 1.3 million cases of tuberculosis
among children under the age of 15 and 450 000
deaths resulting from the disease [1]. Thus, rapid
diagnosis is essential for the prompt initiation of
appropriate therapy and avoidance of progression
of the disease [2].
The diagnosis of tuberculosis in children differs
considerably from that in adults, because of the
difficulties in obtaining microbiological confir-
mation. Pre-adolescent children usually develop
paucibacilar forms of the disease and do not expec-
torate sputum easily. Consequently, conventional
microbiological tests are frequently negative.
Early-morning gastric aspirates from hospitalized
children are the best clinical samples for acid-fast
stain and mycobacterial culture [3]. Gastric aspi-
rates from outpatients [4], induced sputum [5] or
nasopharyngeal aspirates [6] would reduce the
necessity of hospitalization, but the yield of these
samples needs to be evaluated with more studies.
Acid-fast stain of gastric aspirates is usually
negative in children with tuberculosis, and reco-
vering several samples from each child who is
positive is possible in less than 15% [7,8] of the
cases. Although smears are usually specific for
active tuberculosis [9], false-positive results have
been reported [8,10] which have been attributed to
saprophytic mycobacteria. These problems reduce
the clinical utility of smears as a rapid diagnostic
method in childhood tuberculosis.
The isolation of Mycobacterium tuberculosis from
gastric aspirates from children with tuberculosis
is also difficult. Mycobacterial cultures require
several weeks and are positive in only 25–50%
of the cases [8,11,12]; this rate increases consider-
ably in infants less than 1 year of age [13]. Further-
more, the culture yield from other clinical samples
such as bronchoalveolar lavage or cerebrospinal
fluid (CSF) is even lower [14,15]. New liquid sys-
tems have not increased the sensitivity but have
reduced the time to results to 3 weeks, which is still
excessive when evaluating a child with suspected
tuberculosis.
The limits of conventional bacteriology have
stimulated the application of new diagnostic tech-
niques. Great improvements in the direct detection
of M. tuberculosis have resulted from methods
using nucleic acid amplification procedures. In
recent years, PCR has been used as a diagnostic
tool in adult tuberculosis, with sensitivities of 95%
in smear-positive samples and 48% in smear-nega-
tive samples [16]. Nevertheless, few studies have
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evaluated the clinical utility of PCR in childhood
tuberculosis, due to the relatively low number of
children with the disease and the complexity of
obtaining clinical samples.
According to the various studies published, the
sensitivity of in-house PCR in assessing samples of
gastric aspirates from children with pulmonary
tuberculosis varies between 40% and 83% [17–
21]. The reasons for this variability are the lack
of uniformity in the methodology of sample pro-
cessing, the amplified target of M. tuberculosis and
the way detection of amplified DNA is performed.
A study of 68 children obtained a sensitivity of
83.3% when using Chelex particles for DNA
extraction and amplification of fragment of the
IS6110 insertion element [17]. Consequently, the
yield of PCR is much higher than that of the smear,
and provides a rapid test in a child with suspected
tuberculosis. Moreover, and contrary to what hap-
pens with adults, the reported sensitivity of PCR
has usually been better than that of culture. This
can be explained by the fact that only a small
number of organisms is present in the samples
from children and that a high proportion of myco-
bacteria may not be viable in vitro, as a result of the
microbactericidal action of immune and inflam-
matory cells or the reduced viability attendant on
processing and decontaminating specimens before
culture.
The main clinical benefit of PCR in the diagnosis
of childhood tuberculosis has been found in a
group of patients who usually have negative
smear and culture results: only hilar adenopathy
on chest radiograph, no clinical symptoms and
unidentified source case, or not from within the
household. In these cases, in contrast to traditional
methods, PCR sensitivity does not seem to
decrease significantly [18]. Another advantage of
PCR can be seen in cases of severe tuberculosis,
such as meningitis or miliar tuberculosis, where a
delay in the diagnosis can have fatal consequences.
The results of PCR in cerebrospinal fluid and other
clinical samples from children with tuberculous
meningitis can assist in the rapid diagnosis and
prompt commencement of specific therapy [19].
PCR can detect nucleic acids from dead as well
as live M. tuberculosis and therefore can remain
positive for long periods in patients undergoing
tuberculosis therapy. Thus, this method should be
used only for the initial diagnosis and not for
follow-up evaluations of patients who are receiv-
ing antimycobacterial drugs [22]. Nevertheless,
this characteristic of the PCR can be used to
corroborate the clinical diagnosis of children
undergoing specific therapy when the radiologic
evolution seems to be unsatisfactory. Children
with a clinical diagnosis of tuberculosis usually
start specific therapy without microbiological con-
firmation, due to the low yield of conventional
microbiological techniques. However, in spite of
appropriate therapy, some children present
increases in the parenchymal lesion and the size
of the lymph nodes, as well as atelectasis and air
trapping. In these cases, if the diagnosis is uncer-
tain, PCR can be a complementary tool that sup-
ports the diagnosis of tuberculosis in the child
receiving antituberculous therapy [18].
The specificity of PCR in children with tubercu-
losis has been inconsistent. Some of the studies
published have found that positive PCR results are
specific to tuberculosis [17,18], while others have
reported false-positive results in children with
non-tuberculous diseases and have obtained a
specificity of 80–90% [19,20]. These false-positive
results have been attributed to contamination with
exogenous DNA or amplicon, and force each
laboratory to take extreme measures to avoid con-
tamination. Consequently, positive PCR results
should always be interpreted carefully, taking into
consideration the clinical and epidemiologic con-
text of the child with suspected tuberculosis.
A controversial aspect of PCR in the diagnosis of
children with tuberculosis is that positive results
have been reported not only in children with
tuberculous disease, but also in those with tuber-
culosis infection without apparent disease [17–21].
This puts into question the ability of PCR to dis-
tinguish between infection and disease in children
[19]. Nevertheless, a study concluded that children
with tuberculosis infection and positive PCR
results had mediastinal adenopathies on CT-scan
that were not evident on chest radiographs [18].
This group of patients could present microbiolo-
gical activity detected not only by PCR, but also by
culture [8]. Consequently, these would not be
false-positive results but rather a consequence of
PCR’s higher sensitivity.
Recently, a commercial PCR kit (Amplicor PCR
test, Roche Diagnostic Systems, Branchburg, NJ,
USA) has been developed to avoid the cumber-
some and time-consuming ‘in-house’ PCR techni-
ques [23]. Later, a second-generation kit was
marketed (Cobas—Amplicor, Roche Diagnostic
Systems) which automates the amplification and
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detection, simplifies laboratory set-up, and
decreases the amount of hands-on labor [24]. Pub-
lished studies in children have usually performed
‘in-house’ PCR, and this limits the relevance of
their conclusions for clinical practice. Our working
group published a study comparing an ‘in-house’
PCR technique and an Amplicor test [25]. The
sensitivity of the Amplicor test was lower than
that of ‘in-house’ PCR techniques (44% versus
65%) and similar to that of culture (44%). Further-
more, the Amplicor test gave false-positive results
in four children with non-tuberculous diseases
(specificity: 93%). In another study of 21 children
with tuberculosis, Amplicor was positive in only
three children (14.3%), although these patients
seemed to have a very low bacillary load, because
only two children were culture positive (9.5%) and
none of them were smear positive [26]. Therefore,
the Amplicor test does not seem to be the ideal
PCR test for children with tuberculosis.
In summary, the PCR technique has been incor-
porated as a diagnostic tool for the diagnosis of
tuberculosis in recent years. The benefit of rapid
results and greater sensitivity compared with tra-
ditional methods makes PCR a suitable technique
in assessing childhood tuberculosis, especially
when diagnosis is difficult or when urgent diag-
nosis is needed. However, until advances in PCR
performance specificity are obtained, positive PCR
results must be carefully considered, particularly
if the clinical and epidemiologic context of the
child makes the diagnosis of tuberculosis improb-
able. The commercial Amplicor PCR test lacks
good sensitivity and specificity, and it would be
necessary to develop other commercial easy-to-use
PCR kits that provide better yields. In the mean-
time, PCR will be a supporting tool, together with
epidemiologic data, tuberculin skin test, chest
radiograph and traditional microbiological meth-
ods used to diagnose a child with suspected tuber-
culosis.
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